The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics
Annals of the New York Academy of Sciences · 2026
DOI: 10.1111/nyas.70258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, 2026. Verfasst von Xu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Chin…. Hauptthemen laut MEDLINE: Microbiota, Inflammation, Rhinosinusitis, Nasal Mucosa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangxi Provincial Nature Science Foundation.
Abstract (Originalsprache)
The nasal microbiome, an integral component of the upper respiratory tract's microecological system, plays a pivotal role in inflammatory diseases such as allergic rhinitis and chronic sinusitis, which affect a substantial population and markedly reduce quality of life. A healthy nasal flora and its metabolites are crucial for maintaining immune homeostasis and mucosal barrier integrity. This review comprehensively discusses the pathological mechanisms, immune interactions, and clinical intervention strategies involving the nasal microbiota in nasal inflammation. It has been shown that dysbiosis of the nasal flora disrupts immune function and compromises the epithelial barrier, thereby initiating and exacerbating a vicious cycle of inflammation. Furthermore, the formation of bacterial biofilms and the emergence of drug resistance contribute to persistent and recurrent symptoms. Regarding treatment, while antibiotics may offer short‐term efficacy, they risk aggravating the microbial imbalance. In contrast, therapies including probiotics, novel immunomodulators, and traditional Chinese medicine demonstrate significant therapeutic potential by restoring microbial balance and modulating immune responses. This review synthesizes current research to provide new perspectives for understanding host–microbiome interactions and to guide future clinical treatments and drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Hepatobiliary Medicine, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
- Department of Otolaryngology-Head and Neck Surgery, Jiangdu People's Hospital Affiliated to Yangzhou University, Jiangsu Province, China.
ORCID-Profile: Xu Zhang, Chunhong Yu, Zhiqiang Zhang, Xinyu Huang, Peng Wang
Förderung
- National Natural Science Foundation of China
- Jiangxi Provincial Nature Science Foundation
Zitieren
APA
Zhang, X., Yu, C., Zhang, Z., Liu, M., Huang, X., Bai, D., Yang, R., Wang, P., & Yang, C. (2026). The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.70258
Vancouver
Zhang X, Yu C, Zhang Z, Liu M, Huang X, Bai D, et al. The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics. Annals of the New York Academy of Sciences. 2026. doi:10.1111/nyas.70258
BibTeX
@article{Zhang2026,
author = {Zhang, Xu and Yu, Chunhong and Zhang, Zhiqiang and Liu, Mengyuan and Huang, Xinyu and Bai, Daoming and Yang, Rui and Wang, Peng and Yang, Chunping},
title = {The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics},
journal = {Annals of the New York Academy of Sciences},
year = {2026},
doi = {10.1111/nyas.70258}
}
EUVIMED